THE PECULARITIES OF CORRELATION BETWEEN INSULIN RESISTANCE, CARBOHYDRATE AND LIPID METABOLISM INDICES IN PATIENTS WITH GRAVES’DISEASE
Aim. The number of patients with endocrine disorders in the world, in particular, Graves’ disease is continuously increasing. Recent studies have determined the fact of insulin resistance in thyroid disorders. On the one hand, numerous researches prove correlation of hypothyroidism with arterial hypertension, ischaemic heart disease and lipid metabolism disorder, on the other – carbohydrate metabolism disorder and hyper-sympathicotonia are closely associated with hyperthyroidism. The subject of the research was to study the correlation of insulin resistance, lipid and carbohydrate metabolism indices in patients with Graves’disease.
Material and Methods. During the study 53 (37 female and 16 male) patients with Graves’ disease with noticed IR have been examined. At the beginning, after 3– and 6-months thyreostatic therapy with insulin sensitizers (metformin or pioglitazone) the following investigations have been performed: assessing thyroid-stimulating hormone levels, free thyroxine and triiodothyronine; assessing glycated haemoglobin, glucose, C-peptide and fasting insulin as primary IR markers; calculating НОМА-IR index for analysing tissue sensitivity to insulin; calculating НОМА-β index for evaluating the functional capacity of β-cells of islets of Langerhans; measuring Caro indices to monitor hyperinsulinemia, measuring total cholesterol level, low-density lipoproteins, very-low-density lipoproteins, high-density lipoproteins , triglycerides, for analysing IR in relation to lipid metabolism.
Results. The research results found out that free thyroid hormones and thyroid-stimulating hormone are closely related to lipid metabolism. Thus, thyroid-stimulating hormone was characterized as having direct correlation with low-density lipoproteins, while the free thyroxine inversely correlated with total cholesterol, low-density lipoproteins, and high-density lipoproteins. The free triiodothyronine negatively correlated with high-density lipoproteins. The research has also determined the direct correlation between insulin and free thyroxine, as well as free triiodothyronine in patients with diffuse toxic goitre.
Conclusions. The study proves the presence of insulin resistance in patients with Graves’ disease that generates interest to further study of the changes in insulin sensitivity, relation of insulin resistance to thyroid-stimulating hormone, thyroid hormones and looking for the ways to correct these disorders.
Biondi, B., Kahaly, G. J. (2010). Cardiovascular involvement in patients with different causes of hyperthyroidism. Nature Reviews Endocrinology, 6 (8), 431–443. doi: 10.1038/nrendo.2010.105
Dimitriadis, G., Hatziagelaki, E., Mitrou, P., Lambadiari, V., Maratou, E., Raptis, A. E. et. al. (2011). Effect of Hyperthyroidism on Clearance and Secretion of Glucagon in Man. Experimental and Clinical Endocrinology & Diabetes, 119 (04), 214–217. doi: 10.1055/s-0030-1269880
Pankiv, V. I. (2013). The relationship between the pathology of the thyroid gland and type 2 diabetes. Health of Ukraine, 2, 36–37.
Raboudi, N., Arem, R., Jones, R. H. et. al. (1989). Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism. Journal of Physiology Endocrinology and Metabolism, 256, 159–166.
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedus, L., Brix, T. H. (2013). Hyperthyroidism and psychiatric morbidity: evidence from a Danish nationwide register study. European Journal of Endocrinology, 170 (2), 341–348. doi: 10.1530/eje-13-0708
Kapadia, K. B., Bhatt, P. A., Shah, J. S. (2012). Association between altered thyroid state and insulin resistance. Journal of Pharmacology and Pharmacotherapeutics, 3, 156–160.
Lishchuk, O. Z., Kikhtyak, O. P., Moskva, H. A., Lishchuk, B. F. (2014). Changes in sensitivity to insulin in the pathogenesis of diffuse toxic goiter. Clinical endocrinology and endocrine surgery, 1 (46), 77–82.
Brenta, G. (2011). Why Can Insulin Resistance Be a Natural Consequence of Thyroid Dysfunction? Journal of Thyroid Research, 2011, 1–9. doi: 10.4061/2011/152850
Paul, D. T., Mollah, F. H., Alam, M. K. et. al. (2004). Glycemic status in hyperthyroid subjects. Mymensingh Medical Journal, 13 (1), 71–75.
Bloomgarden, Z. T. (2011). World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: Part 4. Diabetes Care, 34 (10), e152–e157. doi: 10.2337/dc11-1306
Chidakel, A., Mentuccia, D., Celi, F. S. (2005). Peripheral Metabolism of Thyroid Hormone and Glucose Homeostasis. Thyroid, 15 (8), 899–903. doi: 10.1089/thy.2005.15.899
Ortega, E., Koska, J., Pannacciulli, N., Bunt, J. C., Krakoff, J. (2008). Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. European Journal of Endocrinology, 158 (2), 217–221. doi: 10.1530/eje-07-0592
Feng, X. (2000). Thyroid Hormone Regulation of Hepatic Genes in Vivo Detected by Complementary DNA Microarray. Molecular Endocrinology, 14 (7), 947–955. doi: 10.1210/me.14.7.947
Garduno-Garcia, J. D. J., Alvirde-Garcia, U., Lopez-Carrasco, G., Padilla Mendoza, M. E., Mehta, R., Arellano-Campos, O. et. al. (2010). TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology, 163 (2), 273–278. doi: 10.1530/eje-10-0312
Antonelli, A., Fallahi, P., Ferrari, S. M. et. al. (2011). 3,5-diiodo-L-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. Journal of Biological Regulators & Homeostatic Agents, 25 (4), 655–660.
Lishchuk, O. Z., Kikhtyak, O. P., Moskva, H. A. (2016). The analysis of results of PPAR-γ agonist pioglitazone using in patients with diffuse toxic goiter and insulin resistance. East European Scientific Journal, 10 (2), 40–43.
Borovikov, V. (2001). Statistica: the art of analysis on PC. For professionals. Vol. 1. Saint Petersburg: Piter, 656.
Purohit, P. (2012). Estimation of serum insulin, Homeostasis model assessment-insulin resistance and C-peptide can help identify possible cardiovascular disease risk in thyroid disorder patients. Indian Journal of Endocrinology and Metabolism, 16 (7), 97–103. doi: 10.4103/2230-8210.94263
Dimitriadis, G., Maratou, E., Boutati, E., Kollias, A., Tsegka, K., Alevizaki, M. et. al. (2008). IGF-I increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. European Journal of Endocrinology, 158 (3), 361–366. doi: 10.1530/eje-07-0532
Pavliuk, P. M. (1990). Disordered glucose tolerance in diffuse toxic goiter. Endocrinology problems, 36 (2), 17–21.
👁 554 ⬇ 311
Copyright (c) 2017 Orysia Lishchuk, Olesya Kikhtyak, Khrystyna Moskva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.